baber/WOPTO huggingface dataset:
Patent JP-2000509108-A (JP)
Title: 冷却システムを有する蒸気加熱ローラ
IPC: D21G1/02
Filed: 1996-04-09
Abstract: (57)【要約】
ガス熱キャリヤ媒体（好ましくは、蒸気）によって加熱されるローラまたはロールは、製紙機械の押圧ステーションまたは平滑ステーションにおける使用のために用いられ、軸方向に平行な周辺流路を有し、熱キャリヤ媒体を供給および排出させるための装置に接続されている。加熱されたローラを冷却するために、冷却手段は、加熱／冷却回路に切り換えられ、熱キャリヤ媒体の流れの方向が逆にされ得る。本発明の他の局面によると、ローラの冷却は、熱キャリヤ凝結物を熱キャリヤの戻りフローに混合し、ガス熱キャリヤによる動作と、凝結された熱キャリヤによる動作とを切り換えることによって調節され得る。本発明はさらに、１つのフランジ付きトラニオン上に配置されたローラ駆動部を有するローラに応用される。
Patent JP-2001514510-A (JP)
Title: 細胞表現型に影響を与える因子をコードする核酸配列を同定するための方法
IPC: C12Q1/68
Filed: 1998-02-27
Abstract: (57)【要約】
細胞表現型に影響を与える核酸配列を同定するための方法が開示される。この方法は、レポーター遺伝子の発現レベルが、レポーター発現のレベルを測定するための方法またはデバイスと関連して表現型と相関するレポーター遺伝子を用いる。発現ライブラリーは、細胞に導入され、そしてレポーター発現レベルにおける変化を示す細胞が選択される。選択された細胞から発現ライブラリーインサートが単離されて、これによって、レポーターによって反映される表現型に影響を与える配列について富化されたサブライブラリーを提供する。さらなる回のサブライブラリー導入および細胞選択を実施して、さらに富化されたサブライブラリーを提供し得る。この方法を用いて同定された配列は、細胞表現型の生成に関与するさらなる分子の同一性を確認にするために用いられ得る。
Patent JP-2000509280-A (JP)
Title: 組換えｄｎａ由来ヌクレオキャプシドタンパク質を用いるウイルストランスフェクタントの作製
IPC: C07K14/11
Filed: 1997-04-30
Abstract: (57)【要約】
本発明は、精製RNP複合体または精製ウイルスRNAポリメラーゼの必要性を除去する、ウイルストランスフェクタント（異種核酸を含むウイルス）を産生する方法を提供する。この方法は、一般に、(i)リボ核酸（核酸転写産物）をウイルスの単離された核タンパク質(NP)と組み合わせて、合成リボ核タンパク質複合体(RNP)を形成させる工程；(ii)合成リボ核タンパク質で宿主細胞をトランスフェクトする工程；および(iii)ウイルスの複製が可能な条件下で宿主細胞を維持（培養）する工程、を含む。
Patent JP-2001517255-A (JP)
Title: 接触分解方法
IPC: B01J29/00
Filed: 1998-02-18
Abstract: (57)【要約】
炭化水素原料を接触分解して高収率のＣ 3 〜Ｃ 5 オレフィンを生成するための方法は、前記原料を、約1〜約12の制約指数（Constraint Index）と0.2ミクロンより小さい結晶サイズを有するリン含有ゼオライトとを含む添加剤成分と、約７オングストロームより大きい細孔寸法を有する大型細孔分子ふるいとを含む触媒組成物と、接触させるステップを含む。
Patent JP-2001516400-A (JP)
Title: シアンを含まない１価銅電気めっき液
IPC: C25D3/38
Filed: 1998-03-17
Abstract: (57)【要約】
銅イオン源、２価銅イオンを１価銅イオンに還元することができる還元剤、溶液のpHを約7〜約10の範囲に十分維持するだけの量のアルカリ物質、及びイミドの錯化剤、例えば、スクシンイミド、3-メチル-3-エチルスクシンイミド、3-メチルスクシンイミド、3-エチルスクシンイミド、3,3,4,4-テトラメチルスクシンイミド、又は3,3,4-トリメチルスクシンイミド、又はヒダントイン、例えば、ジメチルヒダントインを含む、銅を１価イオン状態から付着させる実質的にシアンを含まないめっき液。該実質的にシアンを含まないめっき液は、また、導電性塩の少なくとも１種、光沢を与える添加剤、又は合金が含まれる。該還元剤はアルカリ亜硫酸塩、アルカリ重亜硫酸塩、ヒドロキシルアミン、又はヒドラジンである。該銅は、典型的にはCuCl、CuCl 2 、CuSO 4 、又はCu 2 Oの形で溶液１リットルに対して約2〜約30グラムの銅イオン濃度を十分与えるだけの量で供給され、該錯化剤は錯化剤に対する銅イオンのモル比約1:1〜約1:5、好ましくは約1:4を十分与えるだけの量で存在する。該アルカリ物質は典型的にはNaOH、KOH、NH 4 OH、又はNa 2 CO 3 であり、該導電性塩は典型的にはNaCl、KCl、Na 2 SO 4 、K 4 P 2 O 7 、Na 3 PO 4 、C 6 H 5 Na 3 O 7 、C 6 H 11 NaO 7 、NH 4 Cl、又はKNaC 4 H 4 O 6 である。有効な添加剤としては、有機アミン又はオキシアルキルポリアミン、例えば、トリエチレンテトラミン、テトラエチレンペンタミン、及びポリオキシプロピルトリアミンが挙げられる。基板上に銅をめっきするその溶液を調製する方法、及び基板上にその溶液で銅をめっきする方法も開示される。
Patent JP-2000511162-A (JP)
Title: 避妊のための透明帯タンパク質
IPC: C07K14/47
Filed: 1997-05-22
Abstract: (57)【要約】
この発明は，透明帯タンパク質から誘導されたペプチドの、避妊のための使用、及びこのペプチドを含有し、そのぺプチドが免疫的に作用しないような医薬製剤に関する。
Patent JP-2000511170-A (JP)
Title: 医薬組成物
IPC: A61K31/55
Filed: 1997-05-27
Abstract: (57)【要約】
本発明は、１１−［４−［２−（２−ヒドロキシエトキシ）エチル］−１−ピペラジニル］ジベンゾ−［ｂ，ｆ］［１，４］チアゼピンまたはその製剤上認容性の塩からなる徐放性製剤、その製剤を使用する精神病状態および機能亢進の治療方法、ならびにその製剤の製造方法に関する。
Patent JP-2001519946-A (JP)
Title: 非同期イベントの事後データ収集用ループ化ファイル構造を備えたコンピュータ・ファイル・システム
IPC: G06F17/30
Filed: 1998-03-30
Abstract: (57)【要約】
オペレーティング・システムは、記憶位置のクラスタを論理ループ化したファイルに、データを書き込むことに対応するファイル・システムを有する。書き込みは、ループ・モードまたは非ループ・モードで行うことができ、ループ化記録と非ループ化記録との間の遷移にも対応可能である。非同期イベントの発生に先立つ記録は、ループ・モードで行われる。非同期イベントの発生後、オペレーティング・システムによるクラスタへのポインタの操作によって、ループ部分に収集したデータを、その後に収集したデータと継目なく併合する。このように、コンピュータのファイル・システムにおいて用いるための汎用構造を備えることにより、使用可能なメモリ量は、ループ化記録のために大幅に増大する。実際、数分間のフル・モーション放送品質ビデオを捕獲することができる。加えて、このファイル・システムを用いてデータの記憶を処理することによって、アプリケーションは、記録した情報を物理的記録媒体に配する必要がなくなる。このようなファイル・システムは、非同期イベントの発生を捕獲する目的でデータを収集するあらゆる用途において使用可能である。このようなアプリケーションには、モーション・ビデオの記録、監視、検査データ収集、および何らかの任意の「トリガ」状態に先立つイベントを記録する必要があり、しかも大量の記憶を必要とする場合があり得る、その他の種類のシステムが含まれ、しかもこれらに限定される訳ではない。
Patent JP-2001503449-A (JP)
Title: 高分子量ポリアニリンの安定濃厚溶液とそれからなる物品
IPC: D01F6/76
Filed: 1997-05-29
Abstract: (57)【要約】
高分子量ポリアニリンの安定濃縮溶液。高品質の繊維や良好な機械特性を有する他の物品を加工するためには、選ばれたポリマーの溶液濃度を15〜30重量%の範囲内にすべきことは知られている。さらに、ポリマーの溶解特性と矛盾することなく、最も高分子量のものを用いることが好ましい。しかしながら、このような溶液は、本質的には不安定であり、加工がなされる前にゲルを形成する。本発明は、ゲル化抑制剤（GIs）をポリマー溶液に添加し、それによって溶解した高分子量（Mw＞120,000、Mn＞30,000）のエメラルジン塩基型ポリアニリンの高濃度溶液（＞15重量%）を生成する。第2級アミンは、それらの助溶剤として用いられてきたものと比較して低い濃度で、この目的のために用いられてきた。この溶液は長い時間安定であるので、生成した溶液は優れた繊維、フィルム、コーティングや他の物品を形成するために有用であり、GIは非常に低い濃度で存在するので、ポリマーの劣化を引き起こすことはない。有用であることがわかったGIは、助溶剤としては機能せず、溶液のゲル化時間はGIの濃度に比例することが実証された。とくに、もしこえたならば、物品の構造的および電気伝導的な崩壊が生じるようなGIの好ましい濃度が存在する。溶液を加熱することによって、著しく溶解性が改良される。
Patent MX-154635-A (MX)
Inventor: TRINGALI MARIO
IPC: E04B1/19
Filed: 1982-04-29
Abstract: This invention relates to a tridimensional structural element which can be composed with similar elements or with other components to obtain constructions and particularly coverings having low weight and high resistance. In order to obtain the highest possible static resistance, the best working conditions in whatever possible application and the possibility, without the need of any sliding part, of absorbing thermal expansions, the structural element according to the invention comprises a first body having an essentially polygonal plane surface and an even number of sides, six or more than six, as well as a series of bodies each having an essentially triangular plane surface, which derive towards the outside from alternate sides of the first polygonal body and are on planes forming angles to one another and with respect to the polygonal body plane, in such a way that all the theoretical vertices of the bodies simultaneously touch the surface of a curved surface. The structural element, which results to be "geoconverted", can follow any dimensional condition, either modifying the angles between the plane bodies to vary the radius of the surface as touched by the element vertices, or modifying at will, from zero up to a statically acceptable value, the length of the free sides of the polygonal body.
Patent NZ-205497-A (NZ)
Title: Insect chemosterilant compositions containing salicylanilide derivatives
Inventor: VAN GESTEL J F E
IPC: A01N37/40
Filed: 1983-09-05
Abstract: The use of salicylanilides of the formula <CHEM> as insect chemosterilants and insect chemosterilant compositions containing at least one compound of formula (I) as an active ingredient.
Patent NZ-210846-A (NZ)
Title: Xanthine derivatives and pharmaceutical compositions
Inventor: REGNIER G
IPC: C07D473/06
Filed: 1985-01-16
Abstract: Xanthine compounds of the formula:   <IMAGE>   in which: R1 is hydrogen or (C1-C5) alkyl; R2 is hydrogen, (C1-C5) alkyl optionally having a double bond, or benzyl; R3 is hydrogen or methyl; A is (CH2)n, in which n is an integer from 1 to 4, optionally substituted, when n is higher than 1, by hydroxy; X is nitrogen or   <IMAGE>   and the substituents R are each (C1-C5) alkyl or they form together a polymethylene chain from C4 to C6, optionally containing an oxygen or a sulfur atom. These compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of migraine and asthenia.
Patent NZ-226714-A (NZ)
Title: Poultry skinning apparatus
Inventor: CALLSEN HANS
IPC: A22C21/00
Filed: 1988-10-26
Abstract: An apparatus for skinning poultry carcasses, particularly the breast portions thereof is described, from which the wings have been removed. It is the task to suggest a unit integratable into a processing line, which is able to remove the skin in one piece. To achieve this aim the skinning tool has a pair of cone-shaped, meshing and rotating toothed rollers, which can be moved apart mutually and reciprocally counter to spring tension without losing their engagement. By means of a sensor and as a function of the size of the particular poultry carcass, the complete unit is brought into its working position.
Patent NZ-230032-A (NZ)
Title: Microwave sterilisation of ampoules
Inventor: IIJIMA KENICHI
IPC: B65B55/16
Filed: 1989-07-21
Abstract: A rectangular waveguide (3) is provided in communication with a microwave generator (1), and an irradiation furnace (42) formed in its top wall with a slot (4) is provided in communication with the rectangular waveguide (3). Ampules (30) having only lower portions inserted through the slot (4) into the irradiation furnace (42) are transported by conveyor means (60) along the slot (4). A depth (9) of the irradiation furnace (42) and/or a distance (10) between the ampules (30) and a surface (4 min ) of the slot (4) may be adjusted to control sterilizing effect for medical fluid filling the ampule (30).
Patent NZ-243227-A (NZ)
Title: Mechanical fastening system and manufacture thereof - azimuthally angled prongs formed on a substrate from molten material deposited from cells of a depositing member
Inventor: THOMAS DENNIS ALBERT
IPC: A61F13/62
Filed: 1992-06-19
Abstract: The invention is a refastenable mechanical fastening system, made of free formed prongs (22) joined to a substrate (24). The prongs (22) taper and are nonperpendicularly oriented relative to the plane of the substrate. The prongs (22) also have an azimuthal angle relative to the machine direction of the substrate. Each prong (22) has an engaging means (30) projecting laterally from the periphery of the prong. The free formed prongs (22) are manufactured by the process of depositing liquid material onto a moving substrate (24) to form the base of the prong, stretching the liquid material in a direction parallel to the plane of the substrate (24), severing the stretched material to form the distal end and engaging means (30) of the prong (22) and allowing the prong to azimuthally angle. The advantageous usage of the fastening system in an article of manufacture, such as disposable absorbent article specifically a diaper, is also disclosed.
Patent NZ-255074-A (NZ)
Title: 6-[2-(4-hydroxy-4-(4-substituted phenyl)piperidino)-1-hydroxypropyl]-3,4-dihydro-2(1h)-quinolones
Inventor: CHENARD BERTRAND L
IPC: A61K31/47
Filed: 1993-07-23
Abstract: PCT No. PCT/US93/06827 Sec. 371 Date Apr. 25, 1995 Sec. 102(e) Date Apr. 25, 1995 PCT Filed Jul. 23, 1993 PCT Pub. No. WO94/10166 PCT Pub. Date May 11, 1994The present invention is directed to compounds of formula (I), and the pharmaceutically acceptable acid addition salts thereof, wherein R is selected from the group consisting of F,-CF3, -OCH3, -O(C1)alkyl substituted with 1 to 3 fluoro atoms. -O(C2) substituted with 1 to 5 fluoro atoms, and -O(C3)alkyl substituted with 1 to 7 fluoro atoms. The compounds of formula (I) are useful in the treatment of stroke, traumatic brain injury and central nervous system degenerative diseases.
Patent NZ-263094-A (NZ)
Title: Composition comprising fluid-absorbing material and uncompleted cyclodextrin for odour control
Inventor: TRINH TOAN
IPC: C11D3/20
Filed: 1994-03-17
Abstract: The present invention relates to compositions and articles such as catamenials, diapers, pantiliners, paper towels, tissues, underarm shields, etc., which minimize odor caused from body fluids through the incorporation of an effective amount of cyclodextrin, having a particle size of less than 12 microns. Combinations of small particle size cyclodextrins with other odor-controlling materials are also disclosed.
Patent NZ-263153-A (NZ)
Title: Glass wall component connection member; two half connectors clamp wall panel
Inventor: EUTEBACH PETER
IPC: E06B3/54
Filed: 1994-03-24
Abstract: The invention relates to a connector for plate-like wall components (3, 8) in this case glass panes, in particular, with which there is no need for costly glass cutting. Here, only drillings are rather made inside the glass panes into which a connector half (10, 22) is fitted on each side. The connector halves are secured together by a screw (23).
Patent NZ-269548-A (NZ)
Title: Recombinant production of trehalose in plants
Inventor: HOEKEMA ANDREAS
IPC: C12N15/54
Filed: 1994-06-30
Abstract: The present invention provides for the production of trehalose ina plant host due to the presence in said plant host of a plant expressible gene which comprises in sequence: a) a transcriptional initiation region that is functional in said plant host, b) a DNA sequence encoding a trehalose phosphate synthase activity, and optionally c) a transcriptional termination sequence that is functional in said plant host.
Patent NZ-279025-A (NZ)
Title: Disulphonylphenyl tertiary butyl nitrone and medicaments
Inventor: CARNEY JOHN M
IPC: A61P25/28
Filed: 1994-12-22
Abstract: 2,4-disulfonyl  alpha -phenyl-tert-butyl nitrone and its pharmaceutically acceptable salts are disclosed. These materials are useful as pharmaceutical agents for oral or intravenous administration to patients suffering from acute central nervous system oxidation as occurs in a stroke or from gradual central nervous system oxidation which can exhibit itself as progressive central nervous system function loss.
Patent NZ-286920-A (NZ)
Title: Use of combination of hmg-coa reductase inhibitors and of insulin sensitizers for the prevention/treatment of arteriosclerosis or xanthoma
Inventor: TSUJITA YOSHIO
IPC: A61P3/10
Filed: 1996-07-02
Abstract: A combination of one or more HMG-CoA reductase inhibitors (for example pravastatin, lovastatin, simvastatin, fluvastatin, rivastatin or atorvastatin) with one or more insulin sensitizers (for example troglitazone, pioglitazone, englitazone, BRL-49653, 5-(4-ä2-Ä1-(4-2'-pyridylphenyl)ethylideneaminooxyÜ-ethoxyübenzylüthiaz olidine-2,4-dione, 5-ä4-(5-methoxy-3-methylimidazoÄ5,4-bÜpyridin-2-yl-methoxy)benzylüthia zolidine-2,4-dione or its hydrochloride, 5-Ä4-(6-methoxy-1-methylbenzimidazol-2-ylmethoxy)benzylÜthiazolidine-2 ,4-dione, 5-Ä4-(1-methylbenzimidazol-2-ylmethoxy)benzylÜthiazolidine-2,4-dione and 5-Ä4-(5-hydroxy-1,4,6,7-tetramethylbenzimidazol-2-ylmethoxy)benzylÜthi azolidine-2,4-dione) exhibits a synergistic effect and is significantly better at preventing and/or treating arteriosclerosis and/or xanthoma than is either of the components of the combination alone.
Patent NZ-292513-A (NZ)
Title: Carbamoyl carbamic acid esters, fungicidal compositions thereof
Inventor: WETTERICH FRANK
IPC: C07C271/22
Filed: 1995-08-19
Abstract: PCT No. PCT/EP95/03303 Sec. 371 Date Mar. 3, 1997 Sec. 102(e) Date Mar. 3, 1997 PCT Filed Aug. 19, 1995 PCT Pub. No. WO96/07638 PCT Pub. Date Mar. 14, 1996Carbamoylcarboxamides of the general formula I    <IMAGE>  (I)  and their salts (R1 is unsubstituted or substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl or an unsubstituted or substituted nonaromatic carbo- or heterocycle; R2 is H or unhalogenated or halogenated alkyl or cycloalkyl; R3 is unsubstituted or substituted alkyl, cycloalkyl or phenylalkyl; R4 is H or one of the radicals R3 or R3 and R4, together with the C atom to which they are bonded, are an unsubstituted or substituted carbo- or heterocycle; R5 independently of these is one of the radicals R2; X independently of one another is hydrogen, unsubstituted or substituted alkyl and/or alkenyl; Y independently of one another and of these is one of the radicals X; p,q independently of one another are 0, 1 or 2; R6 is halogen, cyano, nitro or unsubstituted or substituted alkyl, alkoxy, alkylthio or an unsubstituted or substituted phenyl group bonded via oxygen or sulfur; r is 0, 1, 2 or 3), and compositions containing them, processes for preparation, and the use of the compounds I and the compositions are described.
Patent NZ-293210-A (NZ)
Title: A process for purifying and preparing phytosterol composition derived from a pulping soap
Inventor: NOVAK EGON
IPC: A23L33/15
Filed: 1995-09-29
Abstract: A process for isolating a phytosterol composition from a plant-derived pulping soap where the soap is not derived from a sulphate degradation process is claimed comprising: a)	in the first phase, mixing the pulping soap with a solvent mixture at a temperature from 25-150oC to form a creamy precipitate and b)	in a second phase, purifying from a creamy precipitate a phytosterol composition. The solvent mixture of part a) comprises a ketone selected from RCOR' wherein R and R' are alkyl, an aliphatic hydrocarbon selected from C5-10 hydrocarbons and water and having no alcohol. The phytosterol composition produced above useful as a cholesterol lowering agent is claimed.
Patent NZ-300942-A (NZ)
Title: 1-aryl-2-acylamino-ethane derivatives as neurokinin 1 antagonists
Inventor: GERSPACHER MARC
IPC: A61K31/445
Filed: 1996-02-09
Abstract: PCT No. PCT/EP96/00555 Sec. 371 Date Aug. 21, 1997 Sec. 102(e) Date Aug. 21, 1997 PCT Filed Feb. 9, 1996 PCT Pub. No. WO96/26183 PCT Pub. Date Aug. 29, 19961-Aryl-2-acylaminoethane compounds of formula I wherein R1-R4, X and Am are as defined in the description, have valuable pharmaceutical properties and are especially effective as NK-1 antagonists.
Patent NZ-305626-A (NZ)
Title: Reversible protease inhibitors
Inventor: PALMER JAMES T
IPC: A61K31/44
Filed: 1996-03-21
Abstract: rovided are compounds as depicted and their salts in which n is 0 to 13; A-B represents a linkage selected from -CONR3-, -CH2NR3- and -NR3CO-; Y is -CH(R5)- or -N(R5)-; Z is -(CH2)2-, -C(R6)(R7)- or -N(R7)-; Z1 is -(CH2)2-, -C(R6)(R8)- or -N(R8)-; R1 is H, alkoxycarbonylalkanoyl, carbonylalkoxy, an optionally substituted alkanoyl,cycloalkylcarbonyl, an optionally substituted heterocycloalkylcarbonyl, arylalkoxycarbonyl, carbamoyl, alkylcarbamoyl, dialkylcarbamoyl, arylcarbamoyl, arylalkanoyl, aroyl, alkylsulfonyl, dialkylaminosulfonyl or heteroarylsulfonyl; X represents a bond, -CH2-, or -CH2CH(R4)-, wherein R4 is hydrogen, alkyl or arylalkyl; R9 is cyano, -COOR10, P(O)(OR10)2, -S(O)(NR10)R10, -C(O)R11, -S(O)R11, -CONR12R13, -S(O)2NR12R13, -CONHR14 OR -S(O)2NHR14; and the remaining symbols are defined in the specification.  These compounds are reported to be cysteine protease inhibitors
Patent NZ-314671-A (NZ)
Title: Open-sided  washable clip with attachment for securing to base article and at least two latitudinal members between which a garment is longitudinally located
Inventor: VASBENTER LIESMA
IPC: A41F1/00
Filed: 1998-07-17
Abstract: Clip 1 is secured to base article 3 typically either by threads located on indentations 2 or by fabric adhesive 6.  Garment 5 is longitudinally located between at least two clip latitudinal members.
Patent NZ-324127-A (NZ)
Title: Lubricant and surface conditioner suitable for conversion coated metal surfaces
Inventor: KELLY TIMM L
IPC: C10M173/02
Filed: 1996-11-27
Abstract: An lubricant and surface conditioner layer on formed metal surfaces, particularly aluminum cans that have been previously provided with a chromium oxide conversion coating, can be formed by contacting the cans with an aqueous lubricant and surface conditioner forming composition that contains a component A of at least one oxa acid or methyl ester thereof corresponding to the general formula CH3(CH2)nO(CH2CH2O)xCH2C(O)OR, where each of n and x, which may be the same or different, is a positive integer and R represents H or CH3, and a component B of various stated general formula, with the amount of the component B having a ratio to the amount of the component A from 0.2:1 to 10:1, and drying the cans.
Patent NZ-331219-A (NZ)
Title: Antipathogenic peptides having a non-hemolytic selective cytolytic activity and compositions comprising them
Inventor: SHAI YECHIEL
IPC: A61K31/00
Filed: 1997-02-20
Abstract: A peptide having a selective cytolytic activity manifested in that it has a cytolytic activity on pathogenic cells being cells which are non-naturally occurring within the body consisting of pathogenic organisms and malignant cells; and it is non-hemolytic, namely it has not effect on red blood cells or has a cytolytic effect on red blood cells at concentrations which are substantially higher than that in which it manifests said cytolytic activity, non-hemolytic cytolytic peptide having the following characteristics: a) it is a peptide comprising both L and D amino acid residues b) the peptide has a net positive charge which is greater than 1 and c) the peptide is amphipathic. The peptide is selected from designated peptides 1-7.
Patent NZ-331274-A (NZ)
Title: Tetrakis-pentafluorophenyl borates from pentafluorophenyl Grignard reagents; Grignard reagents
Inventor: ASKHAM FREDRIC
IPC: C07F5/02
Filed: 1997-11-19
Abstract: Pentafluorophenyl Grignard reagents are reacted with a boron trihalide in a non-ethereal solvent such as toluene to produce a tetrakis-pentafluorophenyl borate magnesium halide.  Also included is a method for making a hydrocarbon solution of a Grignard reagent by dissolving the reagent in ether, adding a hydrocarbon, and removing the ether; and a Grignard reagent in a solution in a solvent where the solvent contains no free ether.
Patent NZ-332280-A (NZ)
Title: A process for the production of chromium(III) or manganese(II) salts of short chain fatty acids for use in animal feeds
Inventor: CATRON DOUGLAS H
IPC: A23K1/175
Filed: 1998-01-30
Abstract: A food composition for selectively supplementing trace metals in the diet comprising a substantially pure metal salt of a fatty acid of the formula M(CH3(CH2)xCOO-)y wherein M is manganese or chromium; x is 0-4 and y is an integer equal to the cationic charge of M is claimed. The composition contains less than 8.2 parts per billion of the manganese or chromium.
Patent NZ-332626-A (NZ)
Title: Expansion of dynamic range for video camera
Inventor: SERIZAWA MASAYUKI
IPC: H04N5/235
Filed: 1998-11-05
Abstract: To generate dynamic range expanded video image signals, long and short exposure video signals 1060, 1070 are generated at the same time by the imager 1010 , _1050, the first and second video signals having respectively different continuous effective detection ranges.  The respective signals are synchronized for every corresponding frame by circuit 1050 and the exposure ratio between the first and second exposure intervals is detected at 1140 in response to the drive circuit 1020 of the imager.  The gain adjustment circuit 1150 adjusts the difference between gains of the synchronized first and second video signals in accordance with the exposure ratio.  The combining circuit 1080 generates and outputs a combined video signal from the synchronized gain adjusted first and second video signals in accordance with a mixing control signal from circuit 1083 so that the output video signal has an expanded detection range with the first effective detection range connected to the second effective detection range.
Patent NZ-501403-A (NZ)
Title: Device for attaching at least one unifacial voltaic cell with wires to a glass pane
Inventor: ELMER HUBERT
IPC: H01L31/048
Filed: 1999-05-28
Abstract: Described is a device (1, 107, 201, 301) for fixing a glass panel (2, 101, 202, 314) having voltaic elements to a support (3) positioned at the side of a building. The glass panel (2, 101, 202, 314) is held between two clamping elements (4 and 5). Further described is a coupling bowl (10) is supported on the internal clamping element (5) with adjustable pretension. A permanently elastic spring element (7) is positioned between the coupling bowl (10) and the internal clamping element (5).  The spring permits movement of the coupling bowl (10) relative to the clamping element (5). Also provided are several spatial joints (12 and 13) between the glass panel (2) and the support (4) at the side of the building and to conduct the current through the fixing device (1, 107, 201, 301).
Patent NZ-509199-A (NZ)
Title: A VLA-4 inhibitor: oMePUPA-V
Inventor: LEE WEN-CHERNG
IPC: A61K31/40
Filed: 1999-05-28
Abstract: A cell adhesion inhibitory compound oMePUPA-V, pharmaceutically acceptable esters, salts or isomers thereof and pharmaceutical compositions containing this compound. Also described is the use of the compound in the preparation of a medicament that is useful in the treatment of inflammation, asthma, allergic rhinitis, multiple sclerosis, atherosclerosis, inflammatory bowel disease and multiple myeloma in a mammal.
Patent NZ-509633-A (NZ)
Title: A recombinant chimeric PEG-uricase with a long circulatory life and reduced immunogenicity
Inventor: HERSHFIELD MICHAEL
IPC: A61K48/00
Filed: 1999-08-05
Abstract: Recombinant mammalian urate oxidase (uricase) proteins and nucleic acid molecules encoding same, in particular, uricase proteins which are particularly useful as, for example, intermediates for making improved modified uricase proteins with reduced immunogenicity and increased bioavailability are described.  The protein has been modified to insert one or more lysine residues.